A serine-to-asparagine mutation at position 314 of H5N1 avian influenza virus NP is a temperature-sensitive mutation that interferes with nuclear localization of NP

Archives of Virology

Volumn 158, Issue 6, 2013, Pages 1151-1157

  Siboonnan, Nattamon ^a   Wiriyarat, Wittawat ^b   Boonarkart, Chompunuch ^a   Chakritbudsabong, Warunya ^b   Jongkaewwattana, Anan ^c   Puthavathana, Pilaipan ^a   Auewarakul, Prasert ^a   Suptawiwat, Ornpreya ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; CORE PROTEIN; NP PROTEIN, INFLUENZA A VIRUS; RNA BINDING PROTEIN; SERINE;

AMINO ACID SUBSTITUTION; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; INFLUENZA; INFLUENZA VIRUS A H5N1; MDCK CELL; MOLECULAR CLONING; MOUSE; PHENOTYPE; PHYSIOLOGY; TEMPERATURE; VIROLOGY;

AMINO ACID SUBSTITUTION; ANIMALS; ASPARAGINE; CLONING, MOLECULAR; FEMALE; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; MADIN DARBY CANINE KIDNEY CELLS; MICE; MICE, INBRED BALB C; PHENOTYPE; RNA-BINDING PROTEINS; SERINE; TEMPERATURE; VIRAL CORE PROTEINS;

AVIAN INFLUENZA VIRUS; MAMMALIA; MUS;

EID: 84878536703     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-012-1595-1     Document Type: Article

References (21)

1. Glezen WP (2004) Cold-adapted, live attenuated influenza vaccine. Expert Rev Vaccines 3: 131-139.
2. Isakova-Sivak I, Chen LM, Matsuoka Y, Voeten JT, Kiseleva I, Heldens JG, den Bosch H, Klimov A, Rudenko L, Cox NJ, Donis RO (2011) Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2). Virology 412: 297-305.
3. Jin H, Lu B, Zhou H, Ma C, Zhao J, Yang CF, Kemble G, Greenberg H (2003) Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60. Virology 306: 18-24.
4. Hatta M, Hatta Y, Kim JH, Watanabe S, Shinya K, Nguyen T, Lien PS, Le QM, Kawaoka Y (2007) Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. Plos Pathogens 3: 1374-1379.
5. Scull MA, Gillim-Ross L, Santos C, Roberts KL, Bordonali E, Subbarao K, Barclay WS, Pickles RJ (2009) Avian Influenza virus glycoproteins restrict virus replication and spread through human airway epithelium at temperatures of the proximal airways. Plos Pathogens 5: e1000424.
6. Maassab HF (1967) Adaptation and growth characteristics of influenza virus at 25 degrees c. Nature 213: 612-614.
7. Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR (2001) Universal primer set for the full-length amplification of all influenza A viruses. Archives of Virology 146: 2275-2289.
8. Hoffmann E, Krauss S, Perez D, Webby R, Webster RG (2002) Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine 20: 3165-3170.
9. Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG (2000) A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci USA 97: 6108-6113.
10. Wanitchang A, Patarasirin P, Jengarn J, Jongkaewwattana A (2011) Atypical characteristics of nucleoprotein of pandemic influenza virus H1N1 and their roles in reassortment restriction. Arch Virol 156: 1031-1040.
11. Medcalf L, Poole E, Elton D, Digard P (1999) Temperature-sensitive lesions in two influenza A viruses defective for replicative transcription disrupt RNA binding by the nucleoprotein. J Virol 73: 7349-7356.
12. Gabriel G, Herwig A, Klenk HD (2008) Interaction of polymerase subunit PB2 and NP with importin alpha1 is a determinant of host range of influenza A virus. Plos Pathogens 4: e11.
13. Mehle A, Doudna JA (2009) Adaptive strategies of the influenza virus polymerase for replication in humans. Proc Natl Acad Sci USA 106: 21312-21316.
14. Yamada S, Hatta M, Staker BL, Watanabe S, Imai M, Shinya K, Sakai-Tagawa Y, Ito M, Ozawa M, Watanabe T, Sakabe S, Li C, Kim JH, Myler PJ, Phan I, Raymond A, Smith E, Stacy R, Nidom CA, Lank SM, Wiseman RW, Bimber BN, O'Connor DH, Neumann G, Stewart LJ, Kawaoka Y (2010) Biological and structural characterization of a host-adapting amino acid in influenza virus. Plos Pathogens 6: e1001034.
15. O'Neill RE, Jaskunas R, Blobel G, Palese P, Moroianu J (1995) Nuclear import of influenza virus RNA can be mediated by viral nucleoprotein and transport factors required for protein import. J Biol Chem 270: 22701-22704.
16. Wu WW, Pante N (2009) The directionality of the nuclear transport of the influenza A genome is driven by selective exposure of nuclear localization sequences on nucleoprotein. Virol J 6: 68.
17. Wu WW, Sun YH, Pante N (2007) Nuclear import of influenza A viral ribonucleoprotein complexes is mediated by two nuclear localization sequences on viral nucleoprotein. Virol J 4: 49.
18. Weber F, Kochs G, Gruber S, Haller O (1998) A classical bipartite nuclear localization signal on Thogoto and influenza A virus nucleoproteins. Virology 250: 9-18.
19. Ozawa M, Fujii K, Muramoto Y, Yamada S, Yamayoshi S, Takada A, Goto H, Horimoto T, Kawaoka Y (2007) Contributions of two nuclear localization signals of influenza A virus nucleoprotein to viral replication. J Virol 81: 30-41.
20. Bullido R, Gomez-Puertas P, Albo C, Portela A (2000) Several protein regions contribute to determine the nuclear and cytoplasmic localization of the influenza A virus nucleoprotein. J Gen Virol 81: 135-142.
21. Wang P, Palese P, O'Neill RE (1997) The NPI-1/NPI-3 (karyopherin alpha) binding site on the influenza a virus nucleoprotein NP is a nonconventional nuclear localization signal. J Virol 71: 1850-1856.